Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review

Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma with a poor prognosis and survival rate. Existing therapies for relapsed/refractory (R/R) SS have a low response rate with a short duration time. Herein, we presented three cases of R/R SS treated with the anti-PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao, Liu, Zhaorui, Liu, Jie, Zhang, Wei, Zhou, Daobin, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977601/
https://www.ncbi.nlm.nih.gov/pubmed/35387123
http://dx.doi.org/10.3389/fonc.2022.842123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977601/
https://www.ncbi.nlm.nih.gov/pubmed/35387123
http://dx.doi.org/10.3389/fonc.2022.842123

Ejemplares similares